These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 24067565)

  • 1. The changing immune system in sepsis: is individualized immuno-modulatory therapy the answer?
    Boomer JS; Green JM; Hotchkiss RS
    Virulence; 2014 Jan; 5(1):45-56. PubMed ID: 24067565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression.
    Patil NK; Bohannon JK; Sherwood ER
    Pharmacol Res; 2016 Sep; 111():688-702. PubMed ID: 27468649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the understanding and treatment of sepsis-induced immunosuppression.
    Venet F; Monneret G
    Nat Rev Nephrol; 2018 Feb; 14(2):121-137. PubMed ID: 29225343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PD-1 signaling pathway in sepsis: Does it have a future?
    Chen R; Zhou L
    Clin Immunol; 2021 Aug; 229():108742. PubMed ID: 33905818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune disorders in sepsis and their treatment as a significant problem of modern intensive care.
    Łysenko L; Leśnik P; Nelke K; Gerber H
    Postepy Hig Med Dosw (Online); 2017 Aug; 71(1):703-712. PubMed ID: 28894043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation and Cell Death of the Innate and Adaptive Immune System during Sepsis.
    Nedeva C
    Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppression in patients who die of sepsis and multiple organ failure.
    Boomer JS; To K; Chang KC; Takasu O; Osborne DF; Walton AH; Bricker TL; Jarman SD; Kreisel D; Krupnick AS; Srivastava A; Swanson PE; Green JM; Hotchkiss RS
    JAMA; 2011 Dec; 306(23):2594-605. PubMed ID: 22187279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.
    Hotchkiss RS; Monneret G; Payen D
    Nat Rev Immunol; 2013 Dec; 13(12):862-74. PubMed ID: 24232462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into the apoptotic death of immune cells in sepsis.
    Luan YY; Yao YM; Xiao XZ; Sheng ZY
    J Interferon Cytokine Res; 2015 Jan; 35(1):17-22. PubMed ID: 25007137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach.
    Hotchkiss RS; Monneret G; Payen D
    Lancet Infect Dis; 2013 Mar; 13(3):260-8. PubMed ID: 23427891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of sepsis-induced immunosuppression and immunological modification therapies for sepsis.
    Ono S; Tsujimoto H; Hiraki S; Aosasa S
    Ann Gastroenterol Surg; 2018 Sep; 2(5):351-358. PubMed ID: 30238076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of Dendritic Cell Responses to Sepsis-Induced Immunosuppression and to Susceptibility to Secondary Pneumonia.
    Bouras M; Asehnoune K; Roquilly A
    Front Immunol; 2018; 9():2590. PubMed ID: 30483258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Immune System Regulation in Sepsis: From Innate to Adaptive.
    Qiu Y; Tu GW; Ju MJ; Yang C; Luo Z
    Curr Protein Pept Sci; 2019; 20(8):799-816. PubMed ID: 30843486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy in the context of sepsis-induced immunological dysregulation.
    Wu Y; Wang L; Li Y; Cao Y; Wang M; Deng Z; Kang H
    Front Immunol; 2024; 15():1391395. PubMed ID: 38835773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Advances in sepsis induced immunosuppression and immunomodulation therapy].
    He X; Bo L; Jiang C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Dec; 30(12):1202-1205. PubMed ID: 30592959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sepsis-induced human lymphocyte apoptosis and cytokine production in "humanized" mice.
    Unsinger J; McDonough JS; Shultz LD; Ferguson TA; Hotchkiss RS
    J Leukoc Biol; 2009 Aug; 86(2):219-27. PubMed ID: 19369639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathophysiological basis of surgery-linked sepsis].
    Vollmar B
    Chirurg; 2011 Mar; 82(3):199-207. PubMed ID: 21249327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppression after sepsis: systemic inflammation and sepsis induce a loss of naïve T-cells but no enduring cell-autonomous defects in T-cell function.
    Markwart R; Condotta SA; Requardt RP; Borken F; Schubert K; Weigel C; Bauer M; Griffith TS; Förster M; Brunkhorst FM; Badovinac VP; Rubio I
    PLoS One; 2014; 9(12):e115094. PubMed ID: 25541945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunomodulation for sepsis: a change of tack?].
    Leentjens J; Kox M; Pickkers P
    Ned Tijdschr Geneeskd; 2014; 158():A6859. PubMed ID: 24518844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy of Sepsis: Blind Alley or Call for Personalized Assessment?
    Prucha M; Zazula R; Russwurm S
    Arch Immunol Ther Exp (Warsz); 2017 Feb; 65(1):37-49. PubMed ID: 27554587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.